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Subfertility is defined as the inability to conceive, despite regu-
lar sexual intercourse over a period of 12 months, and it af-
fects 10% of couples who wish to have babies. Intrauterine 
insemination (IUI) is accepted as the first-line treatment for 
unexplained infertility and mild male factor subfertility (1-3).
In the literature, many factors affecting pregnancy rates fol-
lowing IUI have been reported. For instance, there are many 
studies related to age (4), the ovarian reserve of females (5) 
and sperm parameters in males (6), and the duration and type 
of infertility (7), which are pre-cycle parameters. Furthermore, 
the effects of cyclic parameters, such as selected ovulation 
induction protocols and the characteristics of the obtained 
follicles, have been evaluated on IUI outcomes in different 
studies (8-10). Despite all these studies, there is still no con-
sensus on parameters that can predict the chances of clinical 
pregnancy after IUI.
The aim of the present retrospective study was to evaluate IUI 
clinical experiences at a private IVF center covering a 10-year 
period and to define the variables for predicting success.
Material and Methods
The present study comprised an observational trial performed 
in a private in vitro fertilization (IVF) center on subfertile cou-
ples who had applied for treatment between 2002 and 2012, 
and in which the data of 503 IUI cases were reviewed retro-
spectively. Couples with a female <40 years of age and a male 
who had been diagnosed with unexplained and mild male 
subfertility were included in the study. Couples with failure 
to conceive for >12 months, and with normal sperm param-
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Abstract
eters, bilateral patent fallopian tubes, and regular menstrual 
cycles were accepted as cases involving unexplained infertility. 
Sperm samples that had a concentration above 20 million/mL 
according to the World Health Organization 1999 criteria, with 
type a (fast progressive) or type b (medium progressive) motil-
ity rates above 50%, with normal morphology and above 14% 
according to Kruger criteria were accepted as normal (11, 12). 
If the sperms in a sperm analysis did not satisfy the aforemen-
tioned reference criteria, but the total motility count (TMC) was 
above 5 million, then couples were accepted as cases involving 
mild male subfertility. Data from couples with any already deter-
mined causes of infertility, and cycles with ovarian hyperstimu-
lation syndrome (OHSS) were not included in the evaluation.
Ovulation induction was performed in 38 cases, using oral tab-
lets of clomiphene citrate (Klomen; Kocak Farma; İstanbul, Tur-
key), which were started on Day 5 of the cycle and given at a 100 
mg/day dose for five days. Injectable gonadotropin, rFSH [fol-
litropin alpha (Gonal F, Serono; İstanbul, Turkey), or follitropin 
beta (Puregon, MSD; İstanbul, Turkey)] was used in 331 cases, 
and HMG (Menogon, Ferring; İstanbul, Turkey) in 134 cases. In-
jectable gonadotropin was used on Day 2 or Day 3 of the cycle 
at doses of 75–150 units. Follicular developments were followed 
up with transvaginal USG, and dose adjustments were contin-
ued until dominant follicle development (max. dose=300 IU). 
Ovulation triggering was performed using 10000 IU hCG (Preg-
nyl, MSD; İstanbul, Turkey). Sperms were prepared using the 
discontinuous gradient method. Briefly, following liquefaction 
at room temperature, the semen was overlaid on a 40% and 80% 
PureSperm gradient column and centrifuged at 300 g for 20 min 
followed by washing the sperm pellet at 500 g in a non-capaci-
tating buffer. A single insemination of 0.4 mL of sperm suspen-
sion per cycle was performed at 36 h after hCG administration 
under ultrasound guidance. Serum samples were obtained 14 
days after hCG administration for βhCG levels.
The primary outcome measure of this study was the clinical 
pregnancy rate, which was gathered in an attempt to form a 
predictive model for the odds of a clinical pregnancy, defined as 
observable cardiac activity via a transvaginal ultrasound above 
six weeks of gestation in women treated by IUI for subfertility. 
Recorded parameters of maternal age, paternal age, follicle 
stimulating hormone (FSH) levels, duration of subfertility, type 
of female subfertility (primary or secondary), type of male sub-
fertility, method of induction (clomiphene citrate or injectable 
gonadotropin), number of dominant follicles, measured di-
ameter of dominant follicles on the day of hCG, the number of 
the total motile sperm count and the number of motile sperm 
counts, i.e., regarding their speeds, were used to determine the 
prediction model.
The study was ethically approved by the local ethics commit-
tee and the written informed consent of all the participants was 
obtained.
Statistical analysis
For all the statistical analysis, R v.3.1.3 for Windows was used. 
For the missing variables in the FSH levels, a stochastic regres-
sion imputation model was formed, using age and the antral fol-
licle count as covariates. Missing FSH data were then imputed, 
by a adding a random number error term to the predicted FSH 
values. The error term was generated from a normal distribu-
tion with a mean of zero, and a variance equal to the regression 
variance, to introduce variability in the predicted values. To as-
sess the association of the odds of clinical pregnancy with the 
covariates, first a set of univariate logistic regression analyses 
was carried out, in which the odds of clinical pregnancy was 
modeled on each covariate, separately. Second, a multivariable 
logistic regression was used to estimate the adjusted odd ratios 
between the odds of clinical pregnancy and the covariates of in-
terest. Finally, a backward stepwise selection method was used 
to obtain the most explanatory model for the odds of clinical 
pregnancy. The ages of the women were included in the model 
to prevent a confounding effect. To ensure the final model was 
a good fit to the dataset at hand, a goodness of fit of the final 
logistic regression model was assessed using the Deviance and 
Hosmer–Lemeshow tests. The null hypothesis of no difference 
between the null and fitted model was rejected at a significance 
level of 10% according to the Deviance test. P values below 0.10 
were considered statistically significant. All the statistical com-
putations, comparisons, and analyses were performed using 
the Statistical Package for Social Sciences Inc. (SPSS version 
15.0 for Windows, SPSS Inc.; IL, USA).
Results
A total of 47 pregnancies were determined in the 503 IUI cycles 
enrolled in the study. A pregnancy rate of 9.34% per cycle was 
determined, and the conception rates were 3 cases in the clo-
miphene citrate (CC) group, 12 in the human menopausal go-
nadotrophin (hMG) group, and 32 in the FSH group (7.8%, 8.9%, 
and 9.6%, respectively).
Basal FSH levels, the ages of the males and females, the type 
and duration of infertility, and male factor characteristics were 
taken as the basic pre-cycle parameters. The ovulation induc-
tion method, the number of follicles obtained, and the diameter 
of the dominant follicle were evaluated as cycle characteristics. 
The correlations between the presence of clinical conception 
and all of these variables were analyzed.
First, a set of univariate logistic regression analyses was carried 
out, in which the response variable (odds of clinical pregnancy) 
was modeled separately on each covariate. Table 1 displays 
the odds ratio estimates (OR), 95% and 90% confidence inter-
vals, and p values resulting from the univariate analyses. Ac-
cordingly, clinical pregnancy was positively associated with the 
duration of infertility (OR=1.09, p=0.089), secondary infertility 
(OR=1.77, p=0.050), and +4 sperm motility after preparation 
(OR=1.03, p=0.091).
Second, an adjustment analysis was carried out. Multivariate 
logistic regression was used to estimate the adjusted OR’s be-
tween the odds of clinical pregnancy and the covariates of inter-
est. The results of the multivariate analysis are given in Table 2. 
Accordingly, clinical pregnancy was positively associated with 
the secondary infertility (OR=2.51, p=0.008).
A backward selection method was employed to obtain the most 
explanatory model for clinical pregnancy in this study. The ages 
of the women were included in the model to prevent the pos-
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sibility of a confounding effect. Table 3 displays the coefficient 
estimates, p values, estimated odds ratios, and their confidence 
intervals in the resultant model. According to the final model, 
the odds for clinical pregnancy were 1.84 times higher for the 
women who had a secondary infertility. Furthermore, a one unit 
increase in +4 sperm motility creates an increase of 1.03 in the 
odds of achieving a positive outcome.
Discussion
In the literature, conception following IUI shows a wide range of 
gestational variation rates. Actually, the causes of these conflict-
ing results are due to the selected treatment group, diagnostic 
criteria, the techniques used, the mean age of the selected co-
hort, the cause of infertility, and the change in treatment success 
according to the number of treatment cycles. In 1997, Hannoun et 
al. (13) published a study showing a treatment success of 5% in a 
single cycle in a CC+IUI group, and 58.7% in a controlled ovarian 
stimulation (COS)+IUI group in three cycles. Guzick et al. (14) 
retrospectively reviewed 45 published articles about unexplained 
infertility IUI studies, and the author reported clinical gestation 
rates of 8.3% in a CC+IUI group, and 17.1% in an hMG+IUI group. 
Goverde et al. (15) reported clinical gestational rates of 7.4% in 
a natural cycle IUI group, and 8.7% in a COS+IUI group. Finally, 
a European study conducted between 2001 and 2004 found that 
the pregnancy rate per IUI cycle was between 11.4% and 12.6% 
(16). In our study, the obtained clinical gestation rate was 9.34% 
(7.8% in the CC group, 8.9% in the hMG group, and 9.6% in the 
rFSH group), and it was within the wide range.
In the present study, a negative correlation was observed be-
tween the female age, basal FSH levels, and clinical gestational 
rates, but the difference was not statistically significant. In the 
present study, we also observed that as the infertility duration 
became longer, the gestation rates also increased. However, in 
the literature, many studies have indicated that as the age (5, 8, 
17) and infertility duration (7, 17, 18) increase, gestational rates 
decrease. Also, Ibérico et al. (19) reported in a study published 
in 2004 that gestational rates in IUI decreased independently of 
the age through longer infertility durations. Contrary to the lit-
erature, the results of our study indicated that, as infertility du-
ration increases, so does the gestational chance, and that no 
correlation was determined between gestational chance and 
the female or male ages. These might be explained due to the 
gestational rates being calculated per treatment cycle instead 
of per couple in our study. It is possible that, as the infertility 
duration is increased, the cumulative probability of gestation is 
increased in couples because of the increased number of IUI 
cycles.
Table 1. Univariate models
Covariate Coefficient  p OR Confidence interval
FSH (basal) 0.024 0.557 1.025 90% (0.957, 1.097)
Female’s age −0.006 0.827 0.994 90% (0.951, 1.039)
Male’s age −0.033 0.230 0.967 90% (0.923, 1.012)
Duration of infertility 0.083 0.089* 1.086 90% (1.002, 1.177)*
Type of infertility  
(primary/secondary) 0.572 0.050* 1.772 90% (1.096, 2.865)*
Male factor  
(normal/subfertile) −0.537 0.385 0.584 90% (0.211, 1.617)
Method of ovulation 
 induction (CC/FSH/hMG) 0.104 0.685 1.109 90% (0.727, 1.694)
Follicle count 0.145 0.519 1.155 90% (0.799, 1.671)
Dominant follicle size 0.004 0.948 1.004 90% (0.913, 1.104)
Sperm count
(after preparation)  0.001 0.517 1.001 90% (0.998, 1.005)
Sperm motility +4 0.030 0.091* 1.031 90% (1.009, 1.061)*
Sperm motility +3 −0.005 0.690 0.994 90% (0.972, 1.017)
Sperm motility +2 0.009 0.599 1.009 90% (0.981, 1.037)
TPMSC 0.001 0.739 1.001 90% (0.997, 1.004)
*p values less than 0.10 indicate a significant association.
FSH: follicle stimulating hormone; CC: clomiphene citrate; hMG: human meno-
pausal gonadotrophin; TPMSC: total progressive motile sperm count; OD: odds ratio
Table 2. Multivariate model
Covariate Coefficient Standard error z p
FSH −0.001 0.052 −0.013 0.989
Female’s age 0.002 0.043 0.040 0.968
Male’s age −0.054 0.045 −1.205 0.228
Duration of infertility −0.008 0.071 −0.110 0.912
Type of infertility  0.922 0.349 2.640 0.008* 
(primary/secondary) 
Male factor  −0.727 0.669 −1.087 0.277 
(normal/subfertile)
Method of ovulation  0.255 0.296 0.863 0.388 
induction (CC/FSH/hMG)
Follicle count 0.191 0.240 0.793 0.427
Dominant follicle size 0.015 0.065 0.235 0.814
Sperm count 0.001 0.003 0.406 0.684 
(after preparation)  
Sperm motility +4 0.032 0.034 0.938 0.348
Sperm motility +3 −0.006 0.019 −0.310 0.757
Sperm motility +2 0.029 0.023 1.264 0.206
TPMSC −0.001  0.004 −0.369 0.712
FSH: follicle stimulating hormone; CC: clomiphene citrate; hMG: human meno-
pausal gonadotrophin; TPMSC: total progressive motile sperm count
Table 3. Final model
Covariate Coefficient p OR CI
Female’s age −0.021 0.462 0.979 90% (0.932, 1.027)
Type of infertility  0.610 0.049* 1.841 90% (1.104, 3.072)* 
(primary/secondary)
Sperm motility +4 0.029 0.105* 1.029 90% (0.999, 1.061)*
*Hosmer–Lemeshow test, p=0.414.
Deviance test, p=0.089.
OR: odds ratio; CI: confidence interval
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In secondary infertility, it was observed that clinical pregnancy 
rates were 1.84-fold higher than in primary infertility. There are 
many studies in the literature supporting this data (20-22). How-
ever, contradictory conclusions have also been reported. Ibérico 
et al. (19) and Dorjpurev et al. (23) proposed that infertility type 
(primary or secondary) did not affect gestational rates (19, 23).
In the statistical analysis of our cycle data, no statistically sig-
nificant correlation was shown between the ovulation induction 
method and the clinical pregnancy rates following IUI. It has 
been shown in many studies in the literature that the use of FSH 
and hMG is superior to CC use (24-27). Although we observed 
that gestational rates were low in the CC group, we could not 
show the difference due to the small sample size. There was no 
difference between the FSH and hMG groups, which is a find-
ing consistent with the literature. There are many studies in the 
literature reporting that the gonadotropin type affected (28, 29) 
or did not affect (30-32) treatment success rates.
No statistically significant effect was observed between the oth-
er examined cycle parameters, the number of obtained follicles, 
the dominant follicle diameter, and clinical gestation rates. Van 
Rumste et al. (33) reported that multi-follicular development 
in IUI did not improve the chances of pregnancy, but rather in-
creased only the number of multiple gestation possibilities. In 
the meta-analysis containing 11599 cycles, van Rumste (34) 
reported that the development of two follicles increased the 
gestation chance more than that with one follicle development, 
but the development of a higher numbers of follicles did not 
increase the chances of pregnancy (34). In the same study, van 
Rumste reported also that the diameter of the dominant follicle 
did not have a high predictivity. However, Ibérico reported that 
if the diameter of the dominant follicle was >20 mm, then the 
pregnancy rates increased (19) accordingly.
There were no statistically significant effects on our clinical preg-
nancy rates for male factor presence/absence, the number of 
sperms in the prepared sperms for insemination, and the num-
ber of total progressive sperms. It was shown that only a sperm 
presence with +4 motility increased clinical pregnancy rates, 
which might be explained due to this study only including an 
unexplained and mild male subfertile patient group. Cao et al. 
(35) evaluated 1153 IUI cycles in 2014 and reported that a num-
ber of motile sperms lower than 2×106 in the insemination had 
low success rates in IUI, but the author also showed that sperm 
numbers higher than this is increased the observed pregnan-
cy rates. They concluded that IUI can be performed when the 
NMSI (number of motile sperm inseminated) exceeds 2x106. As 
there was no infertile male group in our study, we showed that 
the number of changes in the subfertile sperm group did not af-
fect pregnancy rates. It was further shown that the conception 
success rates increased only if the number of sperms with +4 
motility increased. As sperm motility has a very high predictive 
value in an elevated chance of pregnancy, it is accepted as the 
major determinant of IUI success (36-39).
There are many studies in the literature related to IUI. The 
strength of our study in the literature is that it reviews IUI pro-
cedures that have been performed over a period of 10 years in 
the same clinic with the same team (one embryologist and one 
gynecologist).
The most important limitation of our study is that it was a ret-
rospective trial. We evaluated data only as the gestation rate 
per cycle because we wanted to obtain parameters that had a 
predictive role only for a single cycle. However, subsequently, 
this design revealed some findings that were inconsistent with 
those in the literature, such as age and infertility duration. Fur-
ther, we could have conducted an evaluation of the success 
rates for couples. Additionally, in our study, we did not conduct 
a statistical analysis on multiple gestations.
In conclusion, our study results, which are consistent with those 
in the literature, indicates that IUI success in secondary infertile 
couples who were in the unexplained infertility and mild male 
subfertility groups was higher than in primary infertile couples 
and that the chances of pregnancy increased as sperm num-
bers with +4 motility increased. Success in IUI is multifactorial. 
Synchronization of the couple and the medical team should be 
achieved in parallel with all other factors, such as ovaries, fallo-
pian tubes, endometrium, cervix, vagina, and sperms. It is quite 
difficult to concomitantly evaluate all these parameters and to 
determine a predictive parameter in IUI independent from oth-
er factors. We believe that this is the possible reason for the het-
erogeneity of the study groups in the IUI trials in the literature. 
Further prospective, randomized, controlled, and well-planned 
clinical studies on a large scale and with high subgroup num-
bers are required on this subject.
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